Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and Co and currently in Phase I for Neurodegenerative Diseases.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News
A study of malpractice lawsuits related to active surveillance for prostate cancer found “no evidence of successful malpractice litigation,” leading the authors to conclude that